# Pediatric Study to Evaluate the Efficacy and Safety of Ezetimibe Monotherapy in Children With Primary Hypercholesterolemia (P05522)

> **NCT00867165** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 138 (actual)

## Conditions studied

- Primary Hypercholesterolemia

## Interventions

- **DRUG:** ezetimibe
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00867165
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05-21
- **Primary completion:** 2012-04-13
- **Final completion:** 2012-04-13
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2024-05-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00867165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00867165, "Pediatric Study to Evaluate the Efficacy and Safety of Ezetimibe Monotherapy in Children With Primary Hypercholesterolemia (P05522)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00867165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*